COMMUNIQUÉS West-GlobeNewswire

Mount Tam and Banner Midstream Sign Merger Agreement

27/09/2019 - 15:00

BURLINGTON, VT, Sept. 27, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Mount Tam Biotechnologies, Inc. (OTC: MNTM) ("Mount Tam"), announced that it has signed a Merger Agreement with Banner Midstream Corp. ("Banner [...]

Generex Biotechnology Announces Plans to Establish the NuGenerex Diabetes Research Center in Collaboration With Arizona Endocrinology Group & Paradise Valley Medical Family Medicine

27/09/2019 - 15:00

Integrated, collaborative data systems enable population analytics Generex plans to accelerate the clinical development of Oral-Lyn-2 for Type-2 diabetes and Altsulin ® for Type-1 diabetes MIRAMAR, Fla., Sept. 27, 2019 [...]

HMS Hosts Healthcare Thought Leadership Conference ‘Momentum 2019’

27/09/2019 - 15:00

Healthcare leaders gained insights on the future of the industry in third annual conference IRVING, Texas, Sept. 27, 2019 (GLOBE NEWSWIRE) -- HMS (NASDAQ: HMSY) hosted its third annual forum for healthcare leaders last [...]

Tauriga Sciences, Inc. Invited to Present at Prestigious Industry Event in Beverly Hills, California on October 16, 2019

27/09/2019 - 14:45

New York, NY, Sept. 27, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, [...]

XBiotech Announces Oral Presentation of Atopic Dermatitis Results for Bermekimab at 2019 EADV Congress in Madrid, Spain

27/09/2019 - 14:15

Results of the Company’s Phase 2 Trial to be Presented by Dr. Alice Gottlieb on Saturday, October 12, 2019 AUSTIN, Texas, Sept. 27, 2019 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ: XBIT) announced today that Dr. Alice [...]

AgraFlora Organics renforce son accord d'approvisionnement européen et reçoit une injection de capitaux de 2 000 000 $

27/09/2019 - 14:05

VANCOUVER, Colombie-Britannique, 27 sept. 2019 (GLOBE NEWSWIRE) -- AgraFlora Organics International Inc. (« AgraFlora » ou la « Société ») (CSE: AGRA) (Frankfurt: PU31) (OTCPK: AGFAF) une société internationale de [...]

Forty Seven Inc. to Present at 2019 Cantor Global Healthcare Conference

27/09/2019 - 14:01

MENLO PARK, Calif., Sept. 27, 2019 (GLOBE NEWSWIRE) -- Forty Seven Inc. (NASDAQ:FTSV), a clinical-stage, immuno-oncology company focused on developing therapies to activate macrophages in the fight against cancer, today [...]

Mersana Therapeutics to Present at the 2019 Cantor Global Healthcare Conference

27/09/2019 - 14:00

CAMBRIDGE, Mass., Sept. 27, 2019 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc., (NASDAQ:MRSN) a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates ( [...]

Chimerix to Present at 2019 Cantor Global Healthcare Conference

27/09/2019 - 14:00

DURHAM, N.C., Sept. 27, 2019 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX) today announced that Mike Sherman, Chief Executive Officer, will present a corporate overview at the upcoming 2019 Cantor Global Healthcare [...]

TCR² Therapeutics to Present at the Cantor Global Healthcare Conference

27/09/2019 - 14:00

CAMBRIDGE, Mass., Sept. 27, 2019 (GLOBE NEWSWIRE) -- TCR 2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage immunotherapy company developing the next generation of novel T cell therapies for patients suffering from [...]

Vericel to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference on Friday, October 4, 2019

27/09/2019 - 14:00

CAMBRIDGE, Mass., Sept. 27, 2019 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, president [...]

Matinas BioPharma to Present at the 2019 Cantor Global Healthcare Conference

27/09/2019 - 14:00

BEDMINSTER, N.J., Sept. 27, 2019 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), a clinical stage biopharmaceutical company, today announced that Jerome D. Jabbour, Chief Executive Officer, will [...]

Aravive Announces Participation at the 2019 Cantor Global Healthcare Conference

27/09/2019 - 14:00

HOUSTON, Sept. 27, 2019 (GLOBE NEWSWIRE) -- Aravive, Inc. (Nasdaq: ARAV), a clinical-stage biopharmaceutical company developing treatments designed to halt the progression of life-threatening diseases, including cancer [...]

Krystal Biotech Announces Granting of its First Foreign Patent and Reinforces its IP Portfolio with a New U.S. Patent

27/09/2019 - 14:00

PITTSBURGH, Sept. 27, 2019 (GLOBE NEWSWIRE) -- Krystal Biotech Inc. , (“Krystal”) (NASDAQ: KRYS), a gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from skin [...]

Genocea Announces Poster Presentation at The European Society for Medical Oncology (ESMO) Congress 2019 in Barcelona and Presentation at an Upcoming Investor Conference

27/09/2019 - 14:00

Additional p ositive GEN-009 c linical i mmunogenicity d ata d riven by ATLAS™ to be p resented at ESMO Company to present at the Cantor Fitzgerald 2019 Global Healthcare Conference CAMBRIDGE, Mass., Sept. 27, 2019 ( [...]

Optinose to Present at the 2019 Cantor Global Healthcare Conference

27/09/2019 - 14:00

YARDLEY, Pa., Sept. 27, 2019 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that Chief Executive [...]

REPEAT: AgraFlora Organics Bolsters European Supply Agreement; Receives C$2,000,000 Cash Infusion

27/09/2019 - 14:00

VANCOUVER, British Columbia, Sept. 27, 2019 (GLOBE NEWSWIRE) -- AgraFlora Organics International Inc. (“ AgraFlora ” or the “ Company ”) ( CSE: AGRA) (Frankfurt: PU31) (OTCPK: PUFXF ), a growth oriented and diversified [...]

Roche’s Tecentriq in combination with Avastin shows encouraging results in Phase Ib study of people with unresectable hepatocellular carcinoma

27/09/2019 - 14:00

The study showed a confirmed objective response rate of 36% for people treated with the Tecentriq and Avastin combination in unresectable hepatocellular carcinoma who have not received prior systemic therapy The [...]

Stemline Therapeutics Announces Felezonexor (SL-801) Clinical Data to be Featured at Upcoming ESMO 2019 Congress

27/09/2019 - 13:30

NEW YORK, Sept. 27, 2019 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics, [...]